Rhodes Pharmaceuticals, a subsidiary of AvKARE, distributes a buprenorphine product [1]. This medication is used for opioid dependence treatment and pain relief [2, 3].
What forms of buprenorphine does Rhodes Pharmaceuticals offer?
Rhodes Pharmaceuticals markets buprenorphine in several formulations. These include sublingual films and tablets, commonly prescribed for opioid use disorder [2, 3]. They also offer buprenorphine hydrochloride injection for pain management [4].
How is buprenorphine used to treat opioid dependence?
Buprenorphine, when used for opioid dependence, is typically administered as a sublingual film or tablet [2, 3]. It functions as a partial opioid agonist, meaning it binds to opioid receptors but with less intensity than full agonists like heroin or methadone. This action can reduce cravings and withdrawal symptoms without producing a significant euphoric effect, aiding in recovery [5].
What is the difference between buprenorphine and naloxone combinations?
Many buprenorphine products, particularly those for opioid dependence, are combined with naloxone [2, 3]. Naloxone is an opioid antagonist. When buprenorphine is taken as prescribed (sublingually), the buprenorphine is absorbed and has its intended effect. If the medication is misused by injection, the naloxone is absorbed more rapidly, triggering withdrawal symptoms. This combination is designed to deter misuse and diversion [5].
When do patents for buprenorphine products expire?
The patent landscape for buprenorphine is complex, with various formulations and manufacturing processes covered by different patents. DrugPatentWatch.com tracks these patents and their expiry dates. For specific buprenorphine products, including those distributed by Rhodes Pharmaceuticals, patent expiry information can be found on specialized databases [1].
Who are the competitors for Rhodes Pharmaceuticals' buprenorphine products?
The market for buprenorphine is competitive, with numerous manufacturers and distributors. Other companies offering buprenorphine for opioid dependence include Indivior (maker of Suboxone), Reckitt Benckiser (maker of generic Suboxone), and numerous generic pharmaceutical companies producing both sublingual films and tablets [1, 5]. For pain management formulations, competition also exists from other opioid and non-opioid analgesics [4].
What are the typical side effects of buprenorphine?
Common side effects associated with buprenorphine use can include nausea, vomiting, constipation, headache, dizziness, drowsiness, and sweating [2, 3]. More serious side effects, though less common, may involve respiratory depression, liver problems, and allergic reactions [3].
How is buprenorphine regulated?
Buprenorphine is a Schedule III controlled substance in the United States, regulated by the Drug Enforcement Administration (DEA) [5]. Its dispensing for opioid use disorder requires special waivers for prescribers, though these requirements have been updated. The Food and Drug Administration (FDA) also oversees its approval and manufacturing standards [5].
What clinical data supports buprenorphine's efficacy?
Extensive clinical trials have demonstrated the efficacy of buprenorphine in treating opioid use disorder by reducing illicit opioid use, withdrawal symptoms, and cravings [5]. Studies also support its use in managing moderate to severe pain [4].
What is the pricing of Rhodes Pharmaceuticals' buprenorphine?
Pricing for buprenorphine products can vary significantly based on the specific formulation (film, tablet, injection), dosage, quantity, and whether it is a brand-name or generic product. Insurance coverage and pharmacy pricing also play a role. Rhodes Pharmaceuticals, as a distributor, works with pharmacies and healthcare providers to make its products accessible.
Sources:
1. https://drugpatentwatch.com/
2. https://www.rhodespharma.com/products/buprenorphine-naloxone-sublingual-tablets/
3. https://www.rhodespharma.com/products/buprenorphine-naloxone-sublingual-film/
4. https://www.rhodespharma.com/products/buprenorphine-hcl-injection/
5. https://www.samhsa.gov/medications-abuse-treatment/medications-counseling-related-conditions